Vermeire S, Danese S, Sandborn WJ, Schreiber S, et al. Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease. J Crohns Colitis 2023 Dec 14:jjad199. doi: 10.1093.
PMID: 38096402